April 23 is International FOP Awareness Day: Spreading Rare Disease Awareness
source: pixabay.com

April 23 is International FOP Awareness Day: Spreading Rare Disease Awareness

The International Fibrodysplasia Ossificans Progressiva Association (IFOPA) is gearing up to recognize International FOP Awareness Day this year on April 23, 2021. The event is meant to help spread awareness…

Continue Reading April 23 is International FOP Awareness Day: Spreading Rare Disease Awareness
Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting
source: pixabay.com

Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting

According to a story from globenewswire.com, the clinical company Prothena Corporation plc recently presented encouraging results from its phase 1 clinical trial. This trial was evaluating its investigational product candidate…

Continue Reading Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting
This Drug Saves Niemann-Pick Disease Type C Patients. It’s Being Pulled in Six Months.
source: pixabay.com

This Drug Saves Niemann-Pick Disease Type C Patients. It’s Being Pulled in Six Months.

According to a story from Scary Mommy, mother Sara McGlockin recently received devastating news: the drug that was successfully treating her five year old daughter Marian was being discontinued in…

Continue Reading This Drug Saves Niemann-Pick Disease Type C Patients. It’s Being Pulled in Six Months.
Ayvakit for Gastrointestinal Stromal Tumors Approved in China
source: pixabay.com

Ayvakit for Gastrointestinal Stromal Tumors Approved in China

According to a story from Markets Insider, the biopharmaceutical company CStone Pharmaceuticals has announced that China's National Medical Products Administration (NMPA) has approved avapritinib (marketed as Ayvakit) as a treatment…

Continue Reading Ayvakit for Gastrointestinal Stromal Tumors Approved in China